10x Genomics is a life science technology company building products to interrogate, understand and master biology. Co.'s product portfolio consists of multiple integrated solutions that include instruments, consumables and software. Co.'s Chromium platform, which includes its Chromium Controllers, microfluidic chips and related consumables, enables high-throughput analysis of individual biological components. Co.'s Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Co.'s software is a part of its integrated solutions and is comprised of two parts, analysis and visualization. The TXG stock yearly return is shown above.
The yearly return on the TXG stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the TXG annual return calculation with any dividends reinvested as applicable (on ex-dates).
|